The MYH2 gene inclusion body myopathy genetic test is a specialized diagnostic tool used to identify mutations in the MYH2 gene, which are associated with a rare form of muscle disease known as inclusion body myopathy. This condition is characterized by progressive muscle weakness and wasting, particularly affecting the muscles closest to the center of the body. Early and accurate diagnosis through genetic testing is crucial for managing the symptoms and planning appropriate treatment strategies.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to detect specific mutations in the MYH2 gene that are linked to the development of inclusion body myopathy. The process is highly precise, offering individuals and their healthcare providers valuable insights into the genetic underpinnings of the condition.
The cost of the MYH2 gene inclusion body myopathy genetic test at DNA Labs UAE is 4400 AED. While the price may seem high, the test provides essential information for the proper diagnosis and management of the condition, potentially improving the quality of life for those affected. Patients considering this test are advised to consult with their healthcare provider to discuss its benefits and implications fully.
The PLA2G6 Gene Infantile Neuroaxonal Dystrophy Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the PLA2G6 gene, which are linked to Infantile Neuroaxonal Dystrophy (INAD) Type 1. INAD Type 1 is a rare, inherited neurodegenerative disorder that typically manifests in early childhood, characterized by progressive loss of motor skills and intellectual abilities, leading to severe physical and mental disabilities. The condition is attributed to abnormalities in the PLA2G6 gene, which plays a crucial role in the maintenance of neuronal health.
This genetic test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The test involves analyzing the patient's DNA, obtained through a blood sample, to detect mutations in the PLA2G6 gene that are responsible for INAD Type 1. The outcome of this test can provide crucial information for the diagnosis, management, and understanding of the disease's progression, offering families and healthcare providers valuable insights into the condition.
The cost of the PLA2G6 Gene Infantile Neuroaxonal Dystrophy Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately identify the genetic mutations associated with the disorder, offering a critical step towards the appropriate care and support for affected individuals and their families.
The SCN9A gene insensitivity to pain channelopathy-associated genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SCN9A gene. This gene is crucial for the proper functioning of nerve cells involved in the sensation of pain. Mutations in the SCN9A gene can lead to a rare condition where individuals may not feel pain, known as hereditary sensory and autonomic neuropathy type II (HSAN II) or more broadly, channelopathy-associated insensitivity to pain. This condition can have significant implications for an individual's safety and quality of life, making early diagnosis vital.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the test is set at 4400 AED. Through a comprehensive analysis of the patient's DNA, the test seeks to identify any genetic alterations in the SCN9A gene that may lead to the condition. This information can be crucial for the management and treatment of individuals with or at risk of developing this unique insensitivity to pain, allowing for tailored care plans and preventive measures to ensure their well-being.
The TFG Gene Hereditary Motor and Sensory Neuropathy Okinawa Type Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TFG gene, which are responsible for the rare condition known as Hereditary Motor and Sensory Neuropathy Okinawa Type (HMSN Okinawa). This condition is characterized by a progressive loss of muscle tissue and touch sensation, primarily affecting the peripheral nervous system. The test is crucial for individuals with a family history of the disease or those exhibiting symptoms, providing essential information for managing and treating the condition effectively. The cost of the test is 4400 AED, reflecting the advanced genetic analysis involved in pinpointing the specific mutation within the TFG gene. By opting for this test at DNA Labs UAE, patients and their families can access vital genetic insights, paving the way for personalized treatment plans and interventions.
The TTN Gene Hereditary Myopathy with Early Respiratory Failure (HMERF) Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the TTN gene, which are associated with the development of HMERF. This condition is characterized by progressive muscle weakness, primarily affecting the skeletal muscles and leading to early respiratory failure due to diaphragmatic weakness. The test is crucial for individuals exhibiting symptoms of HMERF or those with a family history of the condition, as early detection can significantly impact management and treatment strategies.
Conducted through a blood sample, the test specifically looks for genetic abnormalities within the titin (TTN) gene, which plays a vital role in muscle elasticity and function. The accuracy and reliability of the test make it a valuable tool in the diagnosis of HMERF, enabling healthcare providers to tailor treatment plans to the individual's genetic profile.
The cost of the TTN Gene Hereditary Myopathy with Early Respiratory Failure Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the TTN gene, offering patients and their families critical insights into their condition and guiding future healthcare decisions.
The "FLNA Gene Heterotopia Periventricular ED Variant Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FLNA gene, which are associated with periventricular nodular heterotopia (PVNH). PVNH is a neurological disorder characterized by the presence of nodules of neurons in inappropriate locations in the brain due to their failure to migrate to their correct positions during early brain development. This condition can lead to a variety of symptoms, including seizures, developmental delay, and coordination problems.
The FLNA gene plays a crucial role in cell structure and movement, and mutations in this gene can disrupt the normal neuronal migration process. The "ED Variant" in the test name refers to a specific variant of the condition that may have distinct genetic characteristics or clinical manifestations.
Offered at a cost of 4400 AED, this genetic test involves analyzing the patient's DNA to identify mutations in the FLNA gene that are indicative of periventricular nodular heterotopia. The test is crucial for accurate diagnosis, allowing for personalized treatment plans that can improve patient outcomes. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test represents a vital resource for individuals exhibiting symptoms of PVNH or those with a family history of the condition, enabling early intervention and management of the disorder.
The FLNA Gene Heterotopia Periventricular X-Linked Dominant Genetic Test is a specialized diagnostic assessment designed to identify mutations in the FLNA gene, which are associated with X-linked periventricular heterotopia (PVNH). This condition is characterized by the abnormal localization of neurons in the brain, leading to a range of neurological symptoms, including epilepsy, developmental delays, and sometimes, issues with coordination and muscle tone. Given the X-linked dominant inheritance pattern, mutations in the FLNA gene can significantly impact both males and females, though the severity and presentation can vary widely.
Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, this test aims to provide crucial information for the diagnosis and management of individuals suspected of having PVNH. The process involves collecting a DNA sample, typically through a blood draw, which is then analyzed for specific mutations in the FLNA gene that are indicative of the disorder.
The cost of the FLNA Gene Heterotopia Periventricular X-Linked Dominant Genetic Test is 4400 AED. This price reflects the comprehensive nature of the test, encompassing the sophisticated techniques used to detect gene mutations, as well as the expertise required to interpret the results accurately. For families affected by neurological conditions or for individuals showing symptoms related to PVNH, this test offers a valuable tool for understanding the genetic basis of the condition and guiding treatment and management decisions.
The RNF39 gene is implicated in various neurological functions, including the process of hippocampal long-term potentiation (LTP), which is fundamental for learning and memory. The RNF39-related genetic test is a specialized diagnostic tool designed to identify mutations or alterations in the RNF39 gene that may affect cognitive functions and neurological health. This test is particularly relevant for individuals experiencing cognitive impairments, memory issues, or other neurological symptoms that could be linked to genetic abnormalities affecting hippocampal LTP.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the RNF39 gene. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify and interpret genetic variations. By undergoing this test, individuals can gain valuable insights into their genetic makeup, potentially leading to personalized treatment plans or interventions to address any identified issues. DNA Labs UAE ensures confidentiality and provides detailed consultations to help individuals understand their results and the implications for their health and well-being.
The DKC1 gene plays a pivotal role in the diagnosis of Hoyeraal-Hreidarsson Syndrome (HHS), a rare and severe variant of Dyskeratosis Congenita. This condition is characterized by multisystem abnormalities, including bone marrow failure, immunodeficiency, and developmental defects. The genetic test for the DKC1 gene specifically targets mutations associated with HHS, offering crucial insights for accurate diagnosis and management of the syndrome.
Performed at DNA Labs UAE, this genetic test is priced at 4400 AED. The laboratory utilizes advanced genomic technologies to ensure precise and reliable detection of mutations within the DKC1 gene. This test is not only vital for confirming the diagnosis of Hoyeraal-Hreidarsson Syndrome but also plays a significant role in guiding treatment decisions, understanding prognosis, and facilitating genetic counseling for affected families. With a focus on accuracy and comprehensive care, DNA Labs UAE stands as a premier facility for genetic testing services in the region.
The SPTLC1 gene is associated with Hereditary Sensory and Autonomic Neuropathy Type I (HSAN1), a rare genetic disorder characterized by loss of sensation and muscle weakness. The SPTLC1 gene plays a crucial role in the biosynthesis of sphingolipids, which are essential components of cell membranes and involved in various cellular functions. Mutations in the SPTLC1 gene lead to the accumulation of toxic substances in nerve cells, causing the symptoms associated with HSAN1.
To diagnose HSAN1, a genetic test targeting the SPTLC1 gene can be conducted. This test is designed to identify mutations in the SPTLC1 gene that are responsible for the disorder. Early diagnosis through genetic testing can facilitate better management of the condition and help in understanding the risk of passing the disorder to future generations.
In the United Arab Emirates, the SPTLC1 gene HSAN1 genetic test is available at DNA Labs UAE. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology to provide accurate and reliable genetic testing services. By opting for this test at DNA Labs UAE, individuals suspected of having HSAN1 or those with a family history of the disorder can gain valuable insights into their genetic makeup, enabling informed decisions regarding their health and the health of their family members.
